About this document

01 - SBAR - Angiotensin II (Giapreza) by nerdyhockey music is a document available to read on EtoBox.

Dr. Farivar has requested the addition of Angiotensin II (Giapreza®) for conditional non-formulary use in cardiac surgery patients experiencing vasoplegia, with a review by the Trinity P&T committee expected in March/April 2023. The medication has shown effectiveness in treating postoperative shock and may reduce atrial fibrillation, but operational challenges such as lack of order support and education for staff need to be addressed. Conditional approval is proposed until May 31, 2023, with usage tracking

Author

nerdyhockey music

Language

EN